NLRP3 and atherosclerosis: Emerging evidence indicates TMAO accelerates the activation of the nucleotide-binding oligomerization domain leucine-rich repeat proteins 3 (NLRP3) inflammasome in not only atherosclerosis but also UVC [7,8].